Calcipotriol
- Generic Name
- Calcipotriol
- Brand Names
- Calcitrene, Dovobet, Dovonex, Enstilar, Sorilux, Taclonex, Wynzora
- Drug Type
- Small Molecule
- Chemical Formula
- C27H40O3
- CAS Number
- 112965-21-6
- Unique Ingredient Identifier
- 143NQ3779B
- Background
Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.
- Indication
For the treatment of moderate plaque psoriasis in adults.
- Associated Conditions
- Plaque psoriasis of the scalp, Psoriasis Vulgaris (Plaque Psoriasis)
Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 10
- Registration Number
- NCT00358384
- Locations
- 🇫🇷
GSK Investigational Site, Paris, France
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris
- Conditions
- Psoriasis Vulgaris
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 360
- Registration Number
- NCT00263718
- Locations
- 🇸🇪
Läkarhuset Vällingby, Vällingby, Sweden
🇩🇪Universitätsklinikum Leipzig, Leipzig, Germany
🇮🇪Waterford Regional Hospital, Waterford, Ireland
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris
- Conditions
- Psoriasis Vulgaris
- First Posted Date
- 2005-11-04
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 320
- Registration Number
- NCT00248456
- Locations
- 🇨🇳
Fudan University First Hospital, Dermatology Department, Shanghai, China
Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis
- Conditions
- Psoriasis of Scalp
- First Posted Date
- 2005-10-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 300
- Registration Number
- NCT00243464
- Locations
- 🇧🇪
Universitair Ziekenhuis Sint Raphaël, Dienst Dermatologie, Leuven, Belgium
🇨🇦Windsor Clinical Research Inc., Windsor, Ontario, Canada
🇩🇰Department of Dermatology, Marselisborg Centres, Aarhus, Denmark
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
- Conditions
- Psoriasis of Scalp
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 800
- Registration Number
- NCT00216879
- Locations
- 🇨🇦
Clinique de Dermatologie, Moncton, Canada
🇩🇰Hørsholm Hospital, Dermatological Department, Hørsholm, Denmark
🇬🇧Monklands Hospital, Department of Dermatology, Airdrie, United Kingdom
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis
- Conditions
- Psoriasis of Scalp
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 1350
- Registration Number
- NCT00216840
- Locations
- 🇩🇪
Georg-August-Universität Göttingen, Abteilung Dermatologie und Venerologie, Göttingen, Germany
🇬🇧Royal Gwent Hospital, Department of Dermatology, Newport, United Kingdom
🇫🇮Policlinic of Dermatology, Medical Reception Centre, Turku, Finland
Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
- Conditions
- Psoriasis of Scalp
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 1485
- Registration Number
- NCT00216827
- Locations
- 🇪🇸
Hospital Virgen de la Macarena, Servicio de Dermatología, Sevilla, Spain
🇬🇧Western Infirmary, Dermatology Department, Glasgow, United Kingdom
🇸🇪Akademiska Sjukhuset, Hudkliniken, Uppsala, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.